Viewing Study NCT01836432


Ignite Creation Date: 2025-12-24 @ 9:47 PM
Ignite Modification Date: 2025-12-27 @ 1:15 PM
Study NCT ID: NCT01836432
Status: TERMINATED
Last Update Posted: 2020-05-28
First Post: 2013-04-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer
Sponsor: NewLink Genetics Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module